New research from the University of Cincinnati demonstrates how specially engineered bacteria taken orally can operate as a delivery system for antiviral therapies and vaccines.
The research, led by Nalinikanth Kotagiri, PhD, was recently published in the journal Gut Microbes.
Study background…